feed,title,long_url,short_url
Benzinga,Creative Medical Technology Holdings (NASDAQ: CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStemâ„¢ For Addressing Chronic Lower Back Pain,https://benzinga.com/general/biotech/23/12/36302180/creative-medical-technology-holdings-nasdaq-celz-granted-fda-clearance-to-begin-phase-12-clinical,https://da.gd/Gfec87
